A share price of Novo Nordisk ADR [NVO] is currently trading at $128.66, up 1.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NVO shares have gain 3.74% over the last week, with a monthly amount glided 2.99%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novo Nordisk ADR [NYSE: NVO] stock has seen the most recent analyst activity on April 12, 2024, when BMO Capital Markets initiated its Outperform rating and assigned the stock a price target of $163. Previously, Morgan Stanley started tracking the stock with Overweight rating on January 23, 2024, and set its price target to $120. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $120 on December 01, 2023. Argus initiated its recommendation with a Buy and recommended $110 as its price target on October 02, 2023. In a note dated July 15, 2022, Morgan Stanley upgraded an Overweight rating on this stock.
Novo Nordisk ADR experienced fluctuations in its stock price throughout the past year between $75.56 and $138.28. Currently, Wall Street analysts expect the stock to reach $163 within the next 12 months. Novo Nordisk ADR [NYSE: NVO] shares were valued at $128.66 at the most recent close of the market. An investor can expect a potential return of 26.69% based on the average NVO price forecast.
Analyzing the NVO fundamentals
Trailing Twelve Months sales for Novo Nordisk ADR [NYSE:NVO] were 35.52B which represents 23.66% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at 0.45%, Pretax Profit Margin comes in at 0.46%, and Net Profit Margin reading is 0.37%. To continue investigating profitability, this company’s Return on Assets is posted at 0.3, Equity is 0.92 and Total Capital is 0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 127.47 points at the first support level, and at 126.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 129.33, and for the 2nd resistance point, it is at 129.99.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Novo Nordisk ADR [NYSE:NVO] is 0.70. In addition, the Quick Ratio stands at 0.50 and the Cash Ratio stands at 0.04. Considering the valuation of this stock, the price to sales ratio is 12.09, the price to book ratio is 40.05 and price to earnings (TTM) ratio is 44.43.
